Aequus Pharmaceuticals Inc. (AQS.V)

CAD 0.01

(0.0%)

Total Debt Summary of Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc.'s latest annual total debt in 2023 was 5.06 Million CAD , up 546.78% from previous year.
Aequus Pharmaceuticals Inc.'s latest quarterly total debt in 2024 Q1 was 5.67 Million CAD , up 12.02% from previous quarter.
Aequus Pharmaceuticals Inc. reported annual total debt of 782.91 Thousand CAD in 2022, down -64.09% from previous year.
Aequus Pharmaceuticals Inc. reported annual total debt of 2.18 Million CAD in 2021, down -6.17% from previous year.
Aequus Pharmaceuticals Inc. reported quarterly total debt of 5.67 Million CAD for 2024 Q1, up 12.02% from previous quarter.
Aequus Pharmaceuticals Inc. reported quarterly total debt of 4.08 Million CAD for 2023 Q3, up 22.39% from previous quarter.

Annual Total Debt Chart of Aequus Pharmaceuticals Inc. (2023 - 2013)

Historical Annual Total Debt of Aequus Pharmaceuticals Inc. (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	5.06 Million CAD	546.78%
2022	782.91 Thousand CAD	-64.09%
2021	2.18 Million CAD	-6.17%
2020	2.32 Million CAD	4.8%
2019	2.21 Million CAD	0.0%
2018	- CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	5.55 Million CAD	9.22%
2024 Q1	5.67 Million CAD	12.02%
2023 Q3	4.08 Million CAD	22.39%
2023 FY	5.06 Million CAD	546.78%
2023 Q4	5.06 Million CAD	23.88%
2023 Q1	2.86 Million CAD	265.48%
2023 Q2	3.33 Million CAD	16.71%
2022 Q1	2.2 Million CAD	1.25%
2022 Q3	2.83 Million CAD	29.38%
2022 Q2	2.18 Million CAD	-0.85%
2022 FY	782.91 Thousand CAD	-64.09%
2022 Q4	782.91 Thousand CAD	-72.35%
2021 Q1	2.08 Million CAD	-10.08%
2021 FY	2.18 Million CAD	-6.17%
2021 Q4	2.18 Million CAD	1.31%
2021 Q3	2.15 Million CAD	1.68%
2021 Q2	2.11 Million CAD	1.3%
2020 Q2	2.4 Million CAD	5.23%
2020 Q3	2.42 Million CAD	0.91%
2020 Q4	2.32 Million CAD	-4.26%
2020 FY	2.32 Million CAD	4.8%
2020 Q1	2.28 Million CAD	3.08%
2019 Q3	2.03 Million CAD	0.56%
2019 Q1	522.04 Thousand CAD	0.0%
2019 Q2	2.02 Million CAD	287.78%
2019 Q4	2.21 Million CAD	8.91%
2019 FY	2.21 Million CAD	0.0%
2018 Q4	- CAD	0.0%
2018 Q2	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 FY	- CAD	0.0%
2018 Q3	- CAD	0.0%
2017 Q4	- CAD	0.0%
2017 Q1	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q3	- CAD	0.0%
2016 Q1	- CAD	0.0%
2016 Q2	- CAD	0.0%
2016 FY	- CAD	0.0%
2016 Q4	- CAD	0.0%
2016 Q3	- CAD	0.0%
2015 Q1	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 FY	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 Q2	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 Q1	- CAD	0.0%
2014 FY	- CAD	0.0%
2013 FY	- CAD	0.0%
2013 Q4	- CAD	0.0%

Peer Total Debt Comparison of Aequus Pharmaceuticals Inc.

Name	Total Debt	Total Debt Difference
CanadaBis Capital Inc.	7.3 Million CAD	30.722%
Decibel Cannabis Company Inc.	40.96 Million CAD	87.638%
Delivra Health Brands Inc.	2.02 Million CAD	-149.816%
Entourage Health Corp.	161.58 Million CAD	96.866%
Lifeist Wellness Inc.	1.26 Million CAD	-299.977%
Cannara Biotech Inc.	45.78 Million CAD	88.94%
Medicure Inc.	544 Thousand CAD	-830.841%
PharmaCielo Ltd.	18.3 Million CAD	72.342%
Rubicon Organics Inc.	10.25 Million CAD	50.643%
BioSyent Inc.	1.22 Million CAD	-314.708%
Voyageur Pharmaceuticals Ltd.	40 Thousand CAD	-12559.44%